B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Researchers track Real-World use of leukemia drug blinatumomab
Knowledge-focused Recruiting nowThis study gathers information from medical records of 200 adults with B-cell acute lymphoblastic leukemia who received the drug blinatumomab as part of their treatment. The goal is to see how many patients achieve complete remission and how long they survive. No new treatments a…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 08:40 UTC
-
Leukemia treatment may erase vaccine immunity – study seeks answers
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) treated for B-cell acute lymphoblastic leukemia with the drug blinatumomab still have protection from routine childhood vaccines. Researchers will measure antibody levels for diseases like tetanus, hepatitis B, …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 08:38 UTC